Removing Zantac From The Market Could Lead To People Developing Esophageal Cancer
Heartburn and acid reflux can cause stomach acid to repeatedly burn the delicate, unprotected tissues of the esophagus causing irritation that could lead to cancer
Monday, August 10, 2020 - If you were relying on Zantac to alleviate serious heartburn symptoms you should immediately consult your physician and seek to stop the condition. Untreated acid reflux could lead to cancer of the esophageal, throat, and mouth.
When the FDA recalled popular anti-heartburn and acid reflux drug Zantac from the markets in the United States, it left consumers with little information as to how to treat their heartburn and acid reflux problems. Web sites and YouTube videos are starting to appear in search results on the internet that offer alternatives to taking the now-banned drug. Some 15 million people per year were reported to use Zantac, and the drugmaker Sanofi dominated the market. The company earned billions from the sale of the world's most popular antacid. Medical professionals on the internet are offering a variety of lifestyle change recommendations and also alternative diets that could help prevent acid indigestion. Zantac stomach cancer attorneys are available for a free consultation and no obligation to file a lawsuit claim.
The easiest and most obvious way to alleviate acid indigestion is to eat less and to lose weight, however, most who were reaching for a Zantac lacked the motivation and discipline to do either. Most people who are obese and can lose at least 10% of their body weight will see their acid reflux eliminated or reduced to manageable levels. WebMD recommends the following lifestyle changes: "Avoid snacking in bed, reduce your alcohol consumption, drink a little baking soda mixed with water, sip peppermint or ginger tea – warm or cold, chew a stick of sugar-free gum after eating (but not mint-flavored gum, as that might make your reflux worse), elevate the head of your bed slightly to keep acid in your stomach, where it belongs, take a probiotic supplement, use a non-PPI antacid, such as calcium-based chewable, Milk of Magnesia, or a commercial sodium bicarbonate drink."
Heartburn and acid reflux is caused by stomach contents spilling back up into the esophagus and is painful and dangerous. Studies indicated that repeated acid reflux can cause cancer of the esophagus. The esophagus does not have a lining like a stomach to protect it from acid and can reflux can cause irritation that can lead to cancer. In the YouTube video titled "Treatments for Heartburn | Gastroesophageal Reflux Disease (GERD)," presented by the Gastrointestinal Society (GS), the authors tell heartburn sufferers to look for reflux symptoms such as heartburn, a sensation of food moving up into the throat or mouth, a bitter or sour taste in the mouth, a persistant sore throat or chronic coughing, difficult, painful swallowing, asthma, chest pain, bad breath, a feeling of a lump in the throat, and an uncomfortable feeling of fullness after meals." The GS tells patients that the symptoms of heartburn and acid reflux can be minimized by eliminating spicy food, coffee, and alcohol. Since everyone is different you should pay attention to what you eat and make you feel worse.
More Recent Heartburn MedicineLawsuit News:
- Zantac Cancer Trials Are In Discovery To Begin In October 2022 | 7/19/2022
- Zantac Cancer Lawsuits Could Hinge On The Validity of Ranitidine Testing Methods | 7/11/2022
- Zantac Cancer Bellwether Trials In California Could Set The Stage For A Global Settlement Offer | 7/5/2022
- The FDA Recommended Protein Pump Inhibitor Drugs Like Prilosec And Nexium That May Damage Health More Than Zantac | 6/23/2022
- Truck Drivers, Firefighters, and Police Officers May Have Taken More Zantac Than People In Other Occupations | 6/20/2022
- Scientists Are Expected To Confirm That Ranidine Causes Gastrointestinal Cancer With Slam Dunk Testimony | 6/9/2022
- Scientific Hearings Will Start This September To Interview Zantac Cancer Expert Witnesses | 5/19/2022
- A Whistleblower Scientist Working For A Chinese Company Thinks NDMA Contamination Started In China | 5/12/2022
- Valisure's String Of Stunning Success Casts Doubt On The FDAs Ability To Police The Health Care Market | 5/2/2022
- Zantac Testing Accusations Heat Up With FDA Investigation Of Online Prescription Drug Testing Lab | 4/25/2022
- Study Finds Ranitidine Degrades Into 10,000 Nanograms of NDMA When Introduced To Simulated Stomach Conditions | 4/6/2022
- Potential Zantac Expert Witnesses Are Being Questioned By Zantac Defense Attorneys | 3/31/2022
- The FDA Requires That Drug Companies Regularly Test Ranitidine And Other Drug For NDMA | 3/24/2022
- Update: Where The Zantac Cancer Multidistrict Litigation (MDL) Stands Today | 3/12/2022
- Zantac Cancer Plaintiffs Look To The First Trial In October In Alameda California | 3/11/2022
- Zantac Cancer Plaintiffs Have Until June 30 To Finalize Their Claim | 3/7/2022
- Zantac Bellwether Trials May Focus On Ranitidine Testing Methods That Could Cause NDMA To Accelerate | 3/1/2022
- Valisure LLC's Motivations And Ranitidine Testing Methods May Not Be Scrutinized Before Trial | 2/24/2022
- Zantac Lawsuits May Go To Trial In California In October Of This Year | 2/18/2022
- Sanofi's History Of Reprehensible Corporate Behavior May Bolster Zantac Cancer Lawsuits | 2/10/2022
Lawyers for Zantac Heartburn Medicine Lawsuits
OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.